Go back

Guides and Manuals: Cervical Cancer

2019

• Methodology to calculate HPV Vaccine Coverage in the Region of the Americas
  

  

• Improving data for decision-making: a toolkit for cervical cancer prevention and control programmes (2019)
  

  

2016

• INTEGRATING HPV TESTING IN CERVICAL CANCER SCREENING PROGRAMS:A MANUAL FOR PROGRAM MANAGERS
  

  

• Comprenhensive Cervical Cancer Control. A guide to essential practice, 2014
  

  

2014

• WHO. Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention, 2013
  

  

2013

• PAHO/WHO. Monitoring national cervical cancer prevention and control programmes: Quality control and quality assurance for visual inspection with acetic acid (VIA)-based programmes. 2013
  

  This guide outlines quality control (QC) and quality assurance (QA) considerations to support introduction or scale-up of visual inspection with acetic acid (VIA) as a screening test for cervical cancer, within the context of national comprehensive cervical cancer prevention and control programmes.

• WHO Guidance Note. Comprehensive cervical cancer prevention and control:a healthier future for girls and women. 2013
  

  Women's cancers, including breast, cervical and ovarian cancer, lead to hundreds of thousands of premature deaths among women. Investments and programmes to prevent and treat women's cancers such as cervical cancer have improved and led to strong reductions in high income countries.

2012

• WHO guidelines. Use of cryotherapy for cervical intraepithelial neoplasia, 2011
  

  

  In 2008, cervical cancer was responsible for 275 000 deaths, of which about 88% occurred in low- and middle-income countries.

2011

• WHO. Use of cryotherapy for cervical intraepithelial neoplasia. Evidence tables, 2011
  

  

  Part 1. Standard grade criteria for grading of evidence and diverse recommendations

2009

• WHO. Global Guidance For Cervical Cancer Prevention and Control, 2009
  

  Cancer of the cervix can be prevented in two ways: preventing initial HPV infection through vaccination and (2) screening for precancerous lesions and providing early treatment to prevent progression to cancer.

2006

• WHO. Preparing for the introduction of HPV Vaccines, 2006
  

  This guidance note is based on a UNFPA/WHO Technical Consultation on HPV Vaccines and Sexual and Reproductive Health Programmes, held in March 2006 in Montreux, Switzerland.

• WHO. Comprehensive Cervical Cancer and Control. A guide to essential practice, 2006
  

  This Guide is intended to help those responsible for providing services aimed at reducing the burden posed by cervical cancer for women, communities and health systems. It focuses on the knowledge and skills needed by...

2004

• ACCP. Planning and implementing cervical cancer prevention and control programs. A manual for managers. 2004
  

  Cervical cancer continues to claim the lives of tens of thousands of women who could have been saved through relatively simple screening for and treatment of precancerous lesions.

2003

• WHO. Adherence to Long-Term Therapies: Evidence for Action, 2003
• WHO-A Practical Manual on Visual Screening for Cervical Neoplasia, 2003
• How Can We Prevent Cervical Cancer? A Guide for Community Facilitators, 2003
• WHO, Colposcopy and treatment of cervical intraepithelial Neoplasia: A beginners' manual, 2003

2000

• PAHO. Deconstructing the Myths of Cervical Cancer, 2000
• PAHO. Planning Appropriate Cervical Cancer Prevention Programs, 2000

Other publications

2012

• PAHO. Situation analysis: VIA screening and cryotherapy treatment in Latin America and the Caribbean, 2012
  

  This report reviews the results of a survey administered to professional managers of cervical cancer programs and participants in the PAHO Workshop on VIA and Cryotherapy held in Guatemala City in June 2011. 

2010

• PAHO. Cervical Cancer Prevention and Control Programs A rapid assessment in 12 countries of Latin, 2010
  

  Cervical cancer is the second most common cancer, both in incidence and mortality, in women of all ages in Latin America (LA). It is currently estimated that 63,068 women are diagnosed with cervical cancer each year, and 29,222 die from this disease.

2003

• PAHO. Visual inspection of the uterine cervix with acetic acid. A critical review and selected articles, 2003
  

  The significantly limited impact of cytology based cervical cancer screening programs in developing countries is now widely recognized. There are several reasons for these limits, ranging from the nature of participation of women in screening programs to the access and timely completion of treatment when necessary.

Technical reports

2013

• Situational Analysis of Cervical Cancer Prevention and Control in the Caribbean
  

  This report summarizes the results of a recent assessment of non-Latin Caribbean country policies and services for cervical cancer prevention and control.   It is intended to provide a snapshot of the currently available services and capacity, and to serve as a reference for program strengthening.  

2011

• PAHO. Workshop on VIA screening and cryotherapy treatment, Guatemala, 2011
  

  Although many countries of Latin America and the Caribbean (LAC) have been using cytology as a screening technique for over 30 years, cervical cancer is still the second most common malignant neoplasm in women of all ages in terms of incidence and mortality...

• PAHO. Progress in Cervical Cancer Prevention: The CCA Report Card, 2011
  

  Based on the laboratory work of Professor zur Hausen and his colleagues and critical Epidemiological studies of Dr. Nubia Muñoz and her colleagues, research over the past decades has shown infection with certain cancer-causing types of human papillomavirus (HPV) to be the necessary, but not sufficient, cause of cervical cancer.

• PAHO/PHAC. Preventing cervical cancer in Latin America. Project report, 2011
  

  Despite its preventable nature and availability of effective new technologies, cervical cancer remains among the leading causes of cancer deaths in women in Latin America and the Caribbean (LAC)...

2010

• PAHO. Report of the Latin American Subregional Meeting on Cervical Cancer Prevention - Panama, 2010
  

  Cervical cancer is the second most common malignant neoplasm in terms of incidence and mortality in women of all ages in the Latin American region. Each year, an estimated 63,068 women are diagnosed with cervical cancer in Latin America, with 29,222 deaths from this disease.

2009

• WHO. Meeting on HPV Vaccine Coverage and Impact Monitoring, Geneva, 2009
  

  A meeting on HPV Vaccine Coverage and Impact Monitoring was held at the World Health ganization (WHO) in Geneva, Switzerland on 16-17 November 2009 to discuss methods for HPV vaccine coverage monitoring and to further delineate objectives and strategies for HPV vaccine impact monitoring.

• WHO. Human Papillomavirus Vaccines, Position Statement, 2009 (En inglés)
  

  In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and vaccine combinations against diseases that have an international public health impact.

Go back